Cutler Group LP Atea Pharmaceuticals, Inc. Put Options Transaction History

Cutler Group LP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 Apr 14, 2022	SELL	$5.5 - $9.19 $79,750 - $133,255	-14,500 Reduced 75.52%	4,700 $13,000
Q4 2021 Jan 18, 2022	BUY	$7.67 - $44.59 $126,555 - $735,735	16,500 Added 611.11%	19,200 $75,000
Q3 2021 Oct 26, 2021	BUY	$21.33 - $35.06 $57,590 - $94,662	2,700 New	2,700 $8,000

112

52.4M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $272M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.